The vanilloid receptor (VR1)‐mediated effects of anandamide are potently enhanced by the cAMP‐dependent protein kinase
Open Access
- 15 June 2001
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 77 (6) , 1660-1663
- https://doi.org/10.1046/j.1471-4159.2001.00406.x
Abstract
The endogenous cannabinoid receptor ligand, anandamide (AEA), is a full agonist of the vanilloid receptor type 1 (VR1) for capsaicin. Here, we demonstrate that the potency and efficacy of AEA at VR1 ...Keywords
This publication has 25 references indexed in Scilit:
- The Activity of Anandamide at Vanilloid VR1 Receptors Requires Facilitated Transport across the Cell Membrane and Is Limited by Intracellular MetabolismJournal of Biological Chemistry, 2001
- Pharmacological differences between the human and rat vanilloid receptor 1 (VR1)British Journal of Pharmacology, 2001
- The endogenous cannabinoid agonist, anandamide stimulates sensory nerves in guinea‐pig airwaysBritish Journal of Pharmacology, 2001
- Structure‐activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferensBritish Journal of Pharmacology, 2001
- Cloning and functional expression of a human orthologue of rat vanilloid receptor-1Pain, 2000
- Role of nitric oxide and septide‐insensitive NK1 receptors in bronchoconstriction induced by aerosolised neurokinin A in guinea‐pigsBritish Journal of Pharmacology, 2000
- The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)British Journal of Pharmacology, 2000
- Specific Involvement of PKC-ε in Sensitization of the Neuronal Response to Painful HeatNeuron, 1999
- Pharmacology of cannabinoid CB1 and CB2 receptorsPharmacology & Therapeutics, 1997
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992